Institut National de la Santé et de la Recherche Médicale (INSERM);Institut Pasteur de Lille;National University of Ireland Maynooth
发明人:
Camille Locht,Bernard Mahon,Heather Kavanagh
申请号：
US16840276
公开号：
US20200282041A1
申请日:
2020.04.03
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to a live attenuated Bordetella pertussis vaccine which is deficient for tracheal cytotoxin (TCT), pertussis toxin (PTX), and dermonecrotic toxin (DNT) for prophylaxis or treatment of an allergen-driven airway pathology.
